Liyan Lv

1.9k total citations · 1 hit paper
21 papers, 1.4k citations indexed

About

Liyan Lv is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Liyan Lv has authored 21 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Liyan Lv's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Liyan Lv is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (5 papers) and Circular RNAs in diseases (5 papers). Liyan Lv collaborates with scholars based in China and United States. Liyan Lv's co-authors include Xingwu Wang, Ling Wei, Ming Yang, Nasha Zhang, Ling Wei, Xianrang Song, Yan Zheng, Jujie Sun, Li Xie and Yue Shen and has published in prestigious journals such as Scientific Reports, Molecular Cancer and Journal of Cellular Biochemistry.

In The Last Decade

Liyan Lv

21 papers receiving 1.4k citations

Hit Papers

Noncoding RNAs in gastric cancer: implications for drug r... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyan Lv China 15 1.0k 913 233 185 139 21 1.4k
Karl X. Knaup Germany 18 528 0.5× 442 0.5× 123 0.5× 100 0.5× 145 1.0× 29 1.1k
Shih Hwa Chiou Taiwan 7 760 0.7× 639 0.7× 519 2.2× 117 0.6× 75 0.5× 10 1.2k
Longchang Jiang Germany 8 674 0.7× 622 0.7× 350 1.5× 102 0.6× 139 1.0× 14 1.1k
Jianjun Li China 18 684 0.7× 671 0.7× 224 1.0× 113 0.6× 84 0.6× 30 1.1k
Jen‐Yu Hung Taiwan 18 788 0.8× 570 0.6× 439 1.9× 363 2.0× 276 2.0× 46 1.4k
Huizhen Zhang China 20 1.4k 1.4× 864 0.9× 236 1.0× 157 0.8× 92 0.7× 40 1.9k
Timothy G. Whitsett United States 18 527 0.5× 266 0.3× 247 1.1× 239 1.3× 81 0.6× 35 996
Qingguang Liu China 21 855 0.8× 531 0.6× 213 0.9× 125 0.7× 141 1.0× 55 1.2k

Countries citing papers authored by Liyan Lv

Since Specialization
Citations

This map shows the geographic impact of Liyan Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Lv more than expected).

Fields of papers citing papers by Liyan Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Lv. The network helps show where Liyan Lv may publish in the future.

Co-authorship network of co-authors of Liyan Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Lv. A scholar is included among the top collaborators of Liyan Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Lv. Liyan Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Shuai, Dehai Che, Hongxue Meng, et al.. (2020). Correction: Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer. Oncotarget. 11(52). 4845–4846. 4 indexed citations
3.
Wei, Ling, Jujie Sun, Nasha Zhang, et al.. (2020). Noncoding RNAs in gastric cancer: implications for drug resistance. Molecular Cancer. 19(1). 62–62. 351 indexed citations breakdown →
4.
Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma. Molecular Cancer. 18(1). 147–147. 246 indexed citations
5.
Wei, Ling, Xingwu Wang, Liyan Lv, et al.. (2019). The emerging role of noncoding RNAs in colorectal cancer chemoresistance. Cellular Oncology. 42(6). 757–768. 72 indexed citations
6.
Li, Qi, Fang Liu, Feng Zhang, et al.. (2018). lncRNA NEAT1 competes against let-7a to contribute to non-small cell lung cancer proliferation and metastasis. Biomedicine & Pharmacotherapy. 103. 1507–1515. 65 indexed citations
7.
Wei, Ling, Li Xie, Xing-Wu Wang, et al.. (2018). Circulating tumor DNA measurement provides reliable mutation detection in mice with human lung cancer xenografts. Laboratory Investigation. 98(7). 935–946. 11 indexed citations
8.
Zhang, Shuai, Dehai Che, Fang Yang, et al.. (2017). Tumor-associated macrophages promote tumor metastasis via the TGF-β/SOX9 axis in non-small cell lung cancer. Oncotarget. 8(59). 99801–99815. 93 indexed citations
9.
Cao, Jingyan, Jin Shi, Liyan Lv, et al.. (2016). Interleukin-22 promotes lung cancer cell proliferation and migration via the IL-22R1/STAT3 and IL-22R1/AKT signaling pathways. Molecular and Cellular Biochemistry. 415(1-2). 1–11. 30 indexed citations
10.
Wei, Ling, Jujie Sun, Xing-Wu Wang, et al.. (2016). Twist may be associated with invasion and metastasis of hypoxic NSCLC cells. Tumor Biology. 37(7). 9979–9987. 32 indexed citations
11.
Xie, Li, Xingguo Song, Xingwu Wang, et al.. (2015). Therapeutic effect of TMZ-POH on human nasopharyngeal carcinoma depends on reactive oxygen species accumulation. Oncotarget. 7(2). 1651–1662. 12 indexed citations
12.
Wei, Ling, Xing-Wu Wang, Jujie Sun, et al.. (2015). Knockdown of Med19 Suppresses Proliferation and Enhances Chemo-sensitivity to Cisplatin in Non-small Cell Lung Cancer Cells. Asian Pacific Journal of Cancer Prevention. 16(3). 875–880. 11 indexed citations
13.
Liu, Fang, Xuefeng Wang, Jiebing Li, et al.. (2015). miR‐34c‐3p functions as a tumour suppressor by inhibiting eIF4E expression in non‐small cell lung cancer. Cell Proliferation. 48(5). 582–592. 39 indexed citations
14.
Wei, L., et al.. (2014). Knockdown of cancerous inhibitor of protein phosphatase 2A may sensitize NSCLC cells to cisplatin. Cancer Gene Therapy. 21(5). 194–199. 16 indexed citations
15.
Lv, Liyan, et al.. (2013). Elevated levels of thrombin‐generating microparticles in stored red blood cells. Vox Sanguinis. 105(1). 11–17. 69 indexed citations
16.
Wei, Ling, Xianrang Song, Jujie Sun, et al.. (2012). Lysyl Oxidase May Play a Critical Role in Hypoxia-Induced NSCLC Cells Invasion and Migration. Cancer Biotherapy and Radiopharmaceuticals. 27(10). 672–677. 36 indexed citations
17.
Song, Bao, Chuanxi Wang, Jie Liu, et al.. (2010). MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. Journal of Experimental & Clinical Cancer Research. 29(1). 29–29. 214 indexed citations
18.
Liu, Yonglei, Xianrang Song, Xing-Wu Wang, et al.. (2010). Effect of chronic intermittent hypoxia on biological behavior and hypoxia‐associated gene expression in lung cancer cells. Journal of Cellular Biochemistry. 111(3). 554–563. 61 indexed citations
19.
Xie, Li, Xianrang Song, Jinming Yu, et al.. (2009). Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs. Journal of Experimental & Clinical Cancer Research. 28(1). 68–68. 23 indexed citations
20.
Zhang, Hai‐Jing, Liyan Lv, Hui Liu, et al.. (2009). Profiling the potential biomarkers for cell differentiation of pancreatic cancer using iTRAQ and 2‐D LC‐MS/MS. PROTEOMICS - CLINICAL APPLICATIONS. 3(7). 862–871. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026